Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

7
Radius Health Strengthens Senior Management Team with Appointment of Chhaya Shah as Senior Vice President of Technical Operations

2h globenewswire
WALTHAM, Mass., July 16, 2018 (GLOBE NEWSWIRE) -- Radius Health, Inc. ("Radius" or the "Company") (Nasdaq:RDUS) today announced the appointment of Chhaya Shah as Senior Vice President of Technical Operations.
ABT SGYP SGYPW RDUS ABT

97
March To Freedom Fund Mid-Year Review

2018-07-13 seekingalpha
The first half of 2018 is already over, so it is time to look back at how our portfolio performed, the purchases we made and to check our income growth.
SOJA LMT GIS XOM O.PRF TWX OPRF CVS ABT NKE HON AAPL ABBV DIS ABT VTR HON SO GILD O MA TWC RB CMI TGT V AFL PEP JNJ CVX DG MSFT SBUX ABBV QCOM

14
Can Established Pharmaceuticals Up Abbott (ABT) Q2 Earnings?

2018-07-12 zacks
Abbott Laboratories’ (ABT - Free Report) Established Pharmaceuticals Division (EPD) business has been recording operational sales growth in the last few quarters. We expect this strength to further get reflected in second-quarter 2018 results, scheduled for release on Jul 18.
ABT RMD SYK MCK RSMDF RMD ABT

56
Danger Zone: Investors Who Don't Insist On Fiduciary Duties

2018-07-10 seekingalpha
After initially invalidating the rule in March, the Fifth Circuit Court of Appeals officially issued an order vacating the rule on June 21st.
WFCNP MS.PRE WFC.PRL MS.PRF NFLX WFC.PRJ MS.PRG MS.PRA ABT BAC WFC.PRT WFC.PRR WFC.PRQ WFC.PRP WFC.PRO WFC.PRN MS WFC.PRY WFC.PRX WFC.PRW WFC.PRV ABT WFC WFC.WS BAC LOGM MS.PRI MS.PRK

10
Dexcom And The Missing Connection Between Stock Price And Fundamental Business

2018-07-09 seekingalpha
A hype will only happen with a new technology or invention, the possibility of a gigantic market and good news that lead to higher expectations.
ABT DXCM ABT

7
U.S. Opposition to Breast-Feeding Resolution Stuns World Health Officials - The New York Times

2018-07-08 nytimes
A resolution to encourage breast-feeding was expected to be approved quickly and easily by the hundreds of government delegates who gathered this spring in Geneva for the United Nations-affiliated World Health Assembly.
ABT NYTAB ABT

21
Forty Seven IPO: Google Has A Stake, But Other Competitors Trade At Lower Valuations

2018-07-06 seekingalpha
Entities affiliated with Google own 5.2% stake in the company. Clients of Wellington Management Company have 6.8% stake as well.
ORPHF ABT MKGAF AMGN CELGZ GILD SURF GOOG TRIL ABT RHHBF ARTH RHHVF MKGAY MRK CELG RHHBY FTSV PDLI

16
AbbVie: The Right Combination Of Dividends And Growth

2018-07-05 seekingalpha
AbbVie (ABBV) is an attractive investment for income seekers, as it offers a 4%+ dividend yield with a lot of growth potential. The company's shares will produce compelling total returns over the coming years, through a combination of earnings growth, share repurchases, and dividend payments.
ABT ABBV ABT ABBV

11
Growth Meets Value At NVE Corporation

2018-07-05 seekingalpha
Smaller sensors and couplers with higher sensitivity and power efficiency will replace the traditional ones in the long run as circuit boards get smaller.
ABT SLAB NVEC TXN AVGO ADI BRCM MXIM ABT

16
Here's Why AbbVie Stock is Good for Your Portfolio's Health

2018-07-05 zacks
AbbVie, Inc. (ABBV - Free Report) shares have outperformed the large-cap pharma industry in the past three months. The stock has returned 1.5% in that timeframe against the industry’s decline of 1.1%.
ABT AMGN ABBV ABT ABBV

7
Hemostemix Formalizes World-Class Scientific Advisory Board

2018-07-05 globenewswire
CALGARY, Alberta, July 05, 2018 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“Hemostemix” or the “Company”) (TSX-V:HEM) is pleased to announce the formalization of its Scientific Advisory Board (“SAB”). Members of the SAB are all leaders in their fields of expertise, which span biochemistry, molecular biology, genomics and medicine. The mandate of the Scientific Advisory Board will be to serve as a strategic resource for Hemostemix to advise on research and development initiatives surrounding its stem cell technology product pipeline and the furtherance of Hemostemix’s clinical pipeline and support the Company’s overall mission.
ABT RVXCF RVX ABT

11
Danger Zone: Investors Who Don't Insist On Fiduciary Duties

2018-07-03 valuewalkpremium
“The DOL fiduciary really made the discussion of fiduciary for consumers mainstream. You can’t un-ring that bell.” – Michael Kitces, Interview with Investment News, June 2, 2018
WFC WFCNP ABT WFC.WS MS.PRE WFC.PRL MS.PRF WFC.PRJ MS.PRG MS.PRA ABT WFC.PRT WFC.PRR WFC.PRQ MS.PRI WFC.PRP WFC.PRO WFC.PRN MS.PRK WFC.PRY MS WFC.PRX WFC.PRW WFC.PRV

131
Abbott Labs And Abbvie - 5 Years Later

2018-07-02 seekingalpha
At the start of 2013, Abbott Laboratories (ABT) spun off its branded pharmaceutical business, which has traded since then as Abbvie Inc. (ABBV). Prior to the split, Abbott Laboratories was a massively diversified healthcare firm with operations in diagnostics, medical devices, nutrition and pharmaceuticals. It was also a Dividend Aristocrat, having paid shareholders consecutively rising dividends since 1973 - at that point, a 40-year record.
ABT ABBV ABT ABBV

284
Top Analyst Upgrades and Downgrades: AT&T, Abbott Labs, Honeywell, Tiffany, Zimmer Biomet and More

2018-06-27 247wallst
The futures traded slightly higher Wednesday morning, and while trade remains an issue, the big story for investors is oil jumping over the $70 a barrel level for the first time since late May. The price shot up Tuesday, buoyed by uncertainty over Libyan crude exports and doubts over OPEC’s ability to boost production quickly enough to prevent a shortfall in global supplies. In addition, reports that the United States wants to cut Iran oil imports to zero also contributed to oil’s price gains.
ABT MRVL HON TIF DB TEVA MS.PRE TEVVF MS.PRF MS.PRG MS.PRA ABT MS.PRI BSX HON T TEVJF MS.PRK NUVA TRI MS

179
Here Are 43 Of 84 'Safer' Healthcare High Yield Dividend Equities For June

2018-06-27 seekingalpha
AbbVie took net gain "safer" June high yield dividend Healthcare honors. Its projected 22.9% net gain is better than Gilead's and way ahead of Novartis's result, per analyst targets of 6/22/18.
ABT GRFS GILD ABT 4508 SNY MDT RHHBF MTZXF NVSEF RHHVF MTZPY NVO JNJ RHHBY NVS ABBV PFE ABBV

Related Articles

CYTX: Cytori Therapeutics Analysis and Research Report

7h - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

CATB: Catabasis Pharmaceuticals Analysis and Research Report

2018-07-13 - Asif

Overview Catabasis Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics based on its proprietary Safely Metabolized And Rationally Targeted linker, or SMART LinkerSM, drug discovery platform. The company's SMART Linker drug discovery platform enables it to engineer product candidates that can simultaneously modulate multiple targets in a disease. The company's proprietary product candidates impact pathways that are central to diseases where efficacy may be optimized by a multiple target approach. Catabasis Pharmaceuticals has applied its SMART Linker drug discovery platform to build an internal pipeline of product candidates for rare diseases, its primary focus, and plan to pursue partnerships to develop additional product candidates. The company's lead product candidate is edasalonexent, formerly known as CAT-1004, which the company believe has the potential to be a disease-modifying...

WMT: Walmart Analysis and Research Report

2018-07-09 - Asif

Overview Walmart Inc. helps people around the world save money and live better – anytime and anywhere – in retail stores and through eCommerce. Through innovation, Walmart is striving to create a customer-centric experience that seamlessly integrates its eCommerce and retail stores in an omni-channel offering that saves time for its customers. Each week, the company serve nearly 270 million customers who visit its more than 11,700 stores and numerous eCommerce websites under 65 banners in 28 countries. The company's strategy is to lead on price, invest to differentiate on access, be competitive on assortment and deliver a great experience. Leading on price is designed to earn the trust of its customers every day by providing a broad assortment of quality merchandise and services at everyday low prices ("EDLP"). EDLP is its pricing philosophy under which the company price items at a low price every day so its customers trust that its prices will not change under frequent prom...

Silicon Investor Message Boards

This table lists all message boards related to ABT / Abbott Laboratories on message board site Silicon Investor.

Westinghouse Air Brake Technologies Corporation (Wabtec Corp ABTG: Ambient Corp (Bulls Board)
Ambient Corporation - ABTG.OB ABT: Abbott Laboratories
ABT - Abbott Labs Autobytel (ABTL) - Buy Autos online
ABTXQ: AgriBioTech, Inc. ABTX: AgriBioTech, Inc.
Able Telecom (ABTE) ABTX - Agribiotech
CUSIP: 002824100